Ding Han, Ding Zhi-Guo, Liu Song, Mao Xu-Nan, Lu Xing-Sheng
Department of Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, The Affiliated to Fudan University, Shanghai 200032, China.
Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
World J Gastroenterol. 2025 Feb 28;31(8):101585. doi: 10.3748/wjg.v31.i8.101585.
Ras-related protein Rab24, which belongs to the small GTPase family, plays a crucial role in regulating intracellular protein trafficking. Dysregulation of has been recently identified in hepatocellular carcinoma (HCC). However, its clinical significance and tumor related effects remain to be further clarified.
To explore the expression pattern of and its role in HCC progression.
The expression profile of was tested in HCC tissues together with adjacent tissues from transcriptional, mRNA, and protein levels. The prognostic role of in HCC was assessed by univariate and multivariate analyses. Clinical outcomes were evaluated by the Kaplan-Meier analysis and log-rank test. The effect of on cell proliferation was tested through cellular experiments and xenograft experiments.
expression was elevated in HCC tissues compared to adjacent liver tissues. High expression of was significantly associated with larger tumor size and advanced tumor stage. Moreover, HCC patients with high expression showed poorer overall survival, and was identified as an independent prognosis factor according to multivariate analysis. By using overexpression and shRNA knockdown strategies in HCC cell lines, we found that can promote HCC proliferation. Finally, we validated that silencing significantly attenuated xenograft growth .
Our study demonstrated that high expression of was significantly correlated with poorer prognosis of HCC patients, indicating the potential of as a novel clinical biomarker and therapeutic target.
Ras相关蛋白Rab24属于小GTP酶家族,在调节细胞内蛋白质运输中起关键作用。最近在肝细胞癌(HCC)中发现其失调。然而,其临床意义和与肿瘤相关的作用仍有待进一步阐明。
探讨Rab24的表达模式及其在HCC进展中的作用。
在HCC组织及其相邻组织中从转录、mRNA和蛋白质水平检测Rab24的表达谱。通过单因素和多因素分析评估Rab24在HCC中的预后作用。通过Kaplan-Meier分析和对数秩检验评估临床结果。通过细胞实验和异种移植实验检测Rab24对细胞增殖的影响。
与相邻肝组织相比,HCC组织中Rab24表达升高。Rab24高表达与更大的肿瘤大小和晚期肿瘤分期显著相关。此外,Rab24高表达的HCC患者总生存期较差,多因素分析确定Rab24为独立预后因素。通过在HCC细胞系中使用过表达和shRNA敲低策略,我们发现Rab24可促进HCC增殖。最后,我们验证了沉默Rab24可显著减弱异种移植瘤生长。
我们的研究表明,Rab24高表达与HCC患者较差的预后显著相关,表明Rab24作为一种新型临床生物标志物和治疗靶点的潜力。